BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 19454653)

  • 1. Pivotal advance: CEACAM1 is a negative coreceptor for the B cell receptor and promotes CD19-mediated adhesion of B cells in a PI3K-dependent manner.
    Lobo EO; Zhang Z; Shively JE
    J Leukoc Biol; 2009 Aug; 86(2):205-18. PubMed ID: 19454653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22.
    Bobbitt KR; Justement LB
    J Immunol; 2000 Nov; 165(10):5588-96. PubMed ID: 11067914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function.
    Wu HJ; Bondada S
    J Clin Immunol; 2009 Jan; 29(1):12-21. PubMed ID: 19067131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD72-mediated B cell activation involves recruitment of CD19 and activation of phosphatidylinositol 3-kinase.
    Venkataraman C; Lu PJ; Buhl AM; Chen CS; Cambier JC; Bondada S
    Eur J Immunol; 1998 Oct; 28(10):3003-16. PubMed ID: 9808169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: CEACAM1: fine-tuned for fine-tuning.
    Chen Z; Chen L; Blumberg RS
    J Leukoc Biol; 2009 Aug; 86(2):195-7. PubMed ID: 19643737
    [No Abstract]   [Full Text] [Related]  

  • 6. Carcinoembryonic antigen-related cell adhesion molecule 1 inhibits proximal TCR signaling by targeting ZAP-70.
    Chen Z; Chen L; Qiao SW; Nagaishi T; Blumberg RS
    J Immunol; 2008 May; 180(9):6085-93. PubMed ID: 18424730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD19 controls Toll-like receptor 9 responses in human B cells.
    Morbach H; Schickel JN; Cunningham-Rundles C; Conley ME; Reisli I; Franco JL; Meffre E
    J Allergy Clin Immunol; 2016 Mar; 137(3):889-98.e6. PubMed ID: 26478008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells.
    Fleischer SJ; Daridon C; Fleischer V; Lipsky PE; Dörner T
    Arthritis Rheumatol; 2016 May; 68(5):1210-21. PubMed ID: 26713408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel binding site for Src homology 2-containing protein-tyrosine phosphatase-1 in CD22 activated by B lymphocyte stimulation with antigen.
    Zhu C; Sato M; Yanagisawa T; Fujimoto M; Adachi T; Tsubata T
    J Biol Chem; 2008 Jan; 283(3):1653-1659. PubMed ID: 18024433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation.
    Fujimoto M; Poe JC; Hasegawa M; Tedder TF
    J Biol Chem; 2001 Nov; 276(48):44820-7. PubMed ID: 11584010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction.
    Poe JC; Hasegawa M; Tedder TF
    Int Rev Immunol; 2001; 20(6):739-62. PubMed ID: 11913948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-4 overcomes the negative influence of cyclic AMP accumulation on antigen receptor stimulated B lymphocytes.
    Venkataraman C; Chelvarajan RL; Cambier JC; Bondada S
    Mol Immunol; 1998 Oct; 35(14-15):997-1014. PubMed ID: 9881695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation between SHP-2, phosphatidyl inositol 3-kinase and phosphoinositol 5-phosphatase in the Fc gamma RIIb mediated B cell regulation.
    Sármay G; Koncz G; Pecht I; Gergely J
    Immunol Lett; 1999 May; 68(1):25-34. PubMed ID: 10397152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD19 differentially regulates BCR signalling through the recruitment of PI3K.
    Xu Y; Fairfax K; Light A; Huntington ND; Tarlinton DM
    Autoimmunity; 2014 Nov; 47(7):430-7. PubMed ID: 24953501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1.
    Wu Y; Nadler MJ; Brennan LA; Gish GD; Timms JF; Fusaki N; Jongstra-Bilen J; Tada N; Pawson T; Wither J; Neel BG; Hozumi N
    Curr Biol; 1998 Sep; 8(18):1009-17. PubMed ID: 9740800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent.
    Xu Y; Beavitt SJ; Harder KW; Hibbs ML; Tarlinton DM
    J Immunol; 2002 Dec; 169(12):6910-8. PubMed ID: 12471124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-tyrosine phosphatase SHP-1 is dispensable for FcgammaRIIB-mediated inhibition of B cell antigen receptor activation.
    Nadler MJ; Chen B; Anderson JS; Wortis HH; Neel BG
    J Biol Chem; 1997 Aug; 272(32):20038-43. PubMed ID: 9242674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular IgC2 constant domains of CEACAMs mediate PI3K sensitivity during uptake of pathogens.
    Voges M; Bachmann V; Naujoks J; Kopp K; Hauck CR
    PLoS One; 2012; 7(6):e39908. PubMed ID: 22768164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inside-out signaling promotes dynamic changes in the carcinoembryonic antigen-related cellular adhesion molecule 1 (CEACAM1) oligomeric state to control its cell adhesion properties.
    Patel PC; Lee HS; Ming AY; Rath A; Deber CM; Yip CM; Rocheleau JV; Gray-Owen SD
    J Biol Chem; 2013 Oct; 288(41):29654-69. PubMed ID: 24005674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEACAM1 specifically suppresses B cell receptor signaling-mediated activation.
    Tsugawa N; Yamada D; Watabe T; Onizawa M; Wang S; Nemoto Y; Oshima S; Tsubata T; Adachi T; Kawano Y; Watanabe M; Blumberg RS; Okamoto R; Nagaishi T
    Biochem Biophys Res Commun; 2021 Jan; 535():99-105. PubMed ID: 33352461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.